SCHEMBL6174137

SCHEMBL6174137

CC(C)OC(=O)Nc1cnccc1C(C)C1(C(C)c2ccncc2NC(=O)OC(C)C)NC(=O)N(c2ccc(S(=O)(=O)C(F)(F)F)cc2)C1=O

nearest known ligand 0.36

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 2/20 0.36
CYP3A4 P08684 1/20 0.36
GAA P10253 1/20 0.36
CYP2C19 P33261 1/20 0.36
ALDH1A1 P00352 1/20 0.36
RXFP1 Q9HBX9 2/20 0.36
NAMPT P43490 1/20 0.35
THRB P10828 1/20 0.34
KMT2A Q03164 2/20 0.33
IGF1R P08069 1/20 0.31
MAPT P10636 1/20 0.31
TP53 P04637 1/20 0.31
MEN1 O00255 1/20 0.31
LMNA P02545 2/20 0.30
HTT P42858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6173613 0.89 KIF11 (0.37) CYP2C9CYP3A4GAACYP2C19ALDH1A1
SCHEMBL6175647 0.89 ALDH1A1 (0.38) CYP2C9CYP3A4GAACYP2C19ALDH1A1
SCHEMBL6174499 0.88 GAA (0.35) CYP2C9CYP3A4GAACYP2C19ALDH1A1
SCHEMBL6173386 0.86 ALDH1A1 (0.41) CYP2C9CYP3A4GAACYP2C19ALDH1A1
SCHEMBL6172115 0.86 IGF1R (0.37) CYP2C9CYP3A4GAACYP2C19ALDH1A1
SCHEMBL6172022 0.85 KMT2A (0.36) CYP2C9CYP3A4GAACYP2C19ALDH1A1
SCHEMBL6170996 0.85 CYP3A4 (0.50) CYP2C9CYP3A4GAACYP2C19ALDH1A1
SCHEMBL6171051 0.84 NAMPT (0.48) CYP2C9NAMPT
SCHEMBL6172506 0.84 NAMPT (0.40) CYP2C9CYP3A4GAACYP2C19ALDH1A1
SCHEMBL6173766 0.84 RXFP1 (0.39) CYP2C9CYP3A4GAACYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed